European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- !!hot!! -

The monograph applies to several categories of oral tablets: Coated tablets (including film-coated and sugar-coated)

The EDQM revises monographs cyclically. The 11th Edition (Ph. Eur. 11) introduced subtle but impactful changes to : European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Sublingual tablets (covered elsewhere), lozenges, or implants. The monograph applies to several categories of oral

Monograph 0478 is not a drug-specific monograph (like Paracetamol Tablets ). Instead, it is a . General monographs apply to all articles of a given type. Therefore, whether you are manufacturing a 500 mg antibiotic tablet or a 25 mg antihistamine tablet, the requirements set forth in Ph. Eur. 0478 are automatically applicable, unless a specific individual monograph overrides a particular test. 11) introduced subtle but impactful changes to :

The Gold Standard of Solid Dosage Forms: A Comprehensive Analysis of European Pharmacopoeia Monograph 0478 (Tablets)

The European Pharmacopoeia (Ph. Eur.) Monograph 0478 establishes mandatory quality standards for tablets in Europe, focusing on uniformity of dosage units, dissolution, and disintegration. A key requirement, particularly from Supplement 9.3, mandates that functional break-marks on tablets must ensure subdivided parts meet strict mass uniformity, aligning with 12th Edition guidelines. For details, see gmp-compliance.org .